The Hidden Cost of the Air We Breathe: How Indoor Air Quality Drives Billions in Productivity Losses
(Photo from Pexels)
Poor indoor air quality is quietly draining billions of dollars from the economy every year, often without organisations realising it. In the United States alone, respiratory infections linked to indoor environments reduce productivity by around US$19.4 billion annually, while asthma and allergies account for a further US$29 billion in lost output through both absenteeism and presenteeism.
Evidence shows that better-managed indoor air quality (IAQ) can reduce these losses enough to deliver a conservative return of US$750–US$800 per employee per year, even before healthcare savings are counted. At the same time, cleaner air has been shown to boost key cognitive skills by up to 61%, directly improving decision-making, crisis response and strategic thinking at work. This case study highlights why IAQ is not just a health concern, but one of the most overlooked drivers of financial performance.
Absenteeism and presenteeism: the hidden cost of poor IAQ
Indoor environments influence employee health and productivity in multiple, measurable ways.
Communicable respiratory infections such as influenza and the common cold reduce productivity by an estimated US$19.4 billion each year in the US alone. Improved IAQ—through better ventilation, filtration and humidity control—has been shown to reduce infection rates by 10–14%, avoiding between US$1.9 billion and US$2.7 billion in lost productivity annually.
Chronic conditions further compound these losses. Asthma and allergies reduce productivity by approximately US$29 billion per year due to repeated absences and presenteeism. Studies show that improved IAQ can reduce asthma and allergy cases by 6–15%, translating into avoided productivity losses of US$2.6–US$6.6 billion across the workforce. While these conditions affect fewer people than seasonal infections, sufferers often experience multiple episodes each year, amplifying their economic impact.
Legionnaires’ disease represents a smaller but critical risk. Affecting up to 10,000 people annually and proving fatal in nearly 1% of cases, it underlines why well-managed IAQ is essential for occupant safety as well as financial risk management.
(Photo by Vitaly Gariev from Pexels)
Productivity and cognitive performance
Beyond reducing illness, IAQ has a powerful effect on how well people think and perform. Controlled studies show that office workers in environments with lower CO₂ and VOC levels can achieve up to a 61% improvement in cognitive function compared with conventional buildings, with the largest gains seen in crisis response, information use and strategy.
This matters because staff costs typically represent around 90% of total business operating costs, far outweighing energy or rental expenses. Even a conservative 1% improvement in productivity can generate a 3.5% increase in operating profit, equivalent to more than US$700 per employee per year for an average US salary.
Financial results and implications
When the impacts of reduced respiratory infections, improved asthma and allergy outcomes, and higher day‑to‑day productivity are combined, the financial case is compelling. A bottom‑up assessment shows that better-managed IAQ can conservatively return US$750–US$800 per employee per year in the US, excluding healthcare costs. Converted to building scale, this equates to roughly US$45–US$93 per employee and US$0.36–US$0.75 per square foot annually, with productivity gains alone delivering a minimum of US$700 per employee.
Indoor air quality is not a “soft” wellbeing issue. By reducing absenteeism, limiting presenteeism, and enabling people to think more clearly, good IAQ delivers measurable financial returns. For organisations focused on resilience, performance and ESG outcomes, clean indoor air is one of the smartest investments they can make.
(Photo by AlphaTradeZone from Pexels)
Sources of information
- Mendell, M. J. et al. Improving the Health of Workers in Indoor Environments: Priority Research Needs for a National Occupational Research Agenda – evidence on how indoor environments affect worker health and productivity.
- Putri, W. C. W. S. et al. Economic burden of seasonal influenza in the United States – estimates of productivity losses linked to influenza and common colds.
- Fendrick, A. M. et al. The Economic Burden of Non-Influenza-Related Viral Respiratory Tract Infection in the United States – broader costs of respiratory infections affecting workplaces.
- Nurmagambetov, T., Kuwahara, R. & Garbe, P. The Economic Burden of Asthma in the United States, 2008–2013 – economic impact of asthma-related absenteeism and reduced performance.
- Lamb, C. E. et al. Economic impact of workplace productivity losses due to allergic rhinitis – employer costs linked to allergies and presenteeism.
- Baker-Goering, M. et al. Economic Burden of Legionnaires’ Disease, United States, 2014 – health risks and economic implications of Legionnaires’ disease.
- Allen, J. G. et al. Associations of Cognitive Function Scores with Carbon Dioxide, Ventilation, and VOC Exposures in Office Workers – links between air quality and cognitive performance.
- World Green Building Council. Health, Wellbeing & Productivity in Offices – evidence connecting healthy buildings with business performance.
- Allen, J. G. & Macomber, J. D. Healthy Buildings: How Indoor Spaces Drive Performance and Productivity – synthesis of research on financial returns from healthy indoor environments.